Global Liquid Biopsy Market By Product Type (Instruments, Consumables Kits and Reagents, Software and Services) By Biomarker Type (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA), Extracellular Vesicles (EVs), Other Biomarker Types) By Technology (Multi-gene-parallel Analysis (NGS) and Single Gene Analysis (PCR Microarrays)) by Application (Cancer, Lung Cancer, Prostate Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Gastrointestinal Cancer, Reproductive Health and Other Applications) By End-use (Hospitals and Laboratories, Specialty Clinics, Academic and Research Centers Other End-Uses) By Clinical Application (Therapy Selection, Treatment Monitoring, Early Cancer Screening, Recurrence Monitoring and Other Clinical Applications) and forecast 2024-2033
- Published date: Jan 2024
- Report ID: 28756
- Number of Pages: 271
- Format:
-
-
-
- ANGLE plc
- Oncimmune
- Guardant Health, Inc.
- Myriad Genetics, Inc.
- Biocept, Inc.
- Lucence Health Inc.
- Freenome Holdings, Inc.
- F. Hoffmann-La Roche Ltd.
- QIAGEN NV Company Profile
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- Epigenomics AG
- Other Key Players
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible